March 12, 2014 / 7:16 AM / in 3 years

BRIEF-Hikma Pharmaceuticals expects 5 pct revenue growth in 2014

1 Min Read

March 12 (Reuters) - Hikma Pharmaceuticals PLC : * In 2014, expect revenue growth of 5 pct * Final dividend $0.13/shr * Total dividend $0.20/shr * Group FY revenue increased 23 pct to $1,365 million * FY adjusted operating margin rose to 30.3 pct from 17.5 pct, reflecting significant improvement in generics and injectables margins * FY profit attributable to shareholders increased 112 pct to $212 million * On adjusted basis, profit attributable to shareholders rose 128% to $274 million * Generics revenue increased 158 pct to $268 million, reflecting very strong doxycycline sales * Global injectables revenue increased 14 pct, driven by a strong performance in the US * Says confident about the prospects for 2014 * Source text for Eikon: * For more news, please click here

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below